JPS5547683A - Immunity controlling agent and antivirulent - Google Patents

Immunity controlling agent and antivirulent

Info

Publication number
JPS5547683A
JPS5547683A JP11743979A JP11743979A JPS5547683A JP S5547683 A JPS5547683 A JP S5547683A JP 11743979 A JP11743979 A JP 11743979A JP 11743979 A JP11743979 A JP 11743979A JP S5547683 A JPS5547683 A JP S5547683A
Authority
JP
Japan
Prior art keywords
activity
carbon atoms
antivirulent
controlling agent
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP11743979A
Other languages
English (en)
Other versions
JPH031309B2 (ja
Inventor
Nooton Saimon Raioneru
Uinsurotsupu Haden Jiyon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
NEWPORT PHARMACEUTICALS
Sloan Kettering Institute for Cancer Research
Original Assignee
NEWPORT PHARMACEUTICALS
Sloan Kettering Institute for Cancer Research
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by NEWPORT PHARMACEUTICALS, Sloan Kettering Institute for Cancer Research filed Critical NEWPORT PHARMACEUTICALS
Publication of JPS5547683A publication Critical patent/JPS5547683A/ja
Publication of JPH031309B2 publication Critical patent/JPH031309B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48—Two nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/28—Oxygen atom
    • C07D473/30—Oxygen atom attached in position 6, e.g. hypoxanthine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/32—Nitrogen atom
    • C07D473/34—Nitrogen atom attached in position 6, e.g. adenine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/36—Sulfur atom
    • C07D473/38—Sulfur atom attached in position 6
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/40—Heterocyclic compounds containing purine ring systems with halogen atoms or perhalogeno-alkyl radicals directly attached in position 2 or 6

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Transplantation (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
JP11743979A 1978-09-15 1979-09-14 Immunity controlling agent and antivirulent Granted JPS5547683A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/942,802 US4221909A (en) 1978-09-15 1978-09-15 P-Acetamidobenzoic acid salts of 9-(hydroxyalkyl) purines

Publications (2)

Publication Number Publication Date
JPS5547683A true JPS5547683A (en) 1980-04-04
JPH031309B2 JPH031309B2 (ja) 1991-01-10

Family

ID=25478620

Family Applications (1)

Application Number Title Priority Date Filing Date
JP11743979A Granted JPS5547683A (en) 1978-09-15 1979-09-14 Immunity controlling agent and antivirulent

Country Status (27)

Country Link
US (1) US4221909A (ja)
EP (1) EP0009154B1 (ja)
JP (1) JPS5547683A (ja)
KR (1) KR840000552A (ja)
AT (1) ATE1949T1 (ja)
AU (1) AU527851B2 (ja)
CA (1) CA1122217A (ja)
CS (1) CS251060B2 (ja)
DD (1) DD146049A5 (ja)
DE (1) DE2964211D1 (ja)
DK (1) DK149857C (ja)
ES (1) ES484167A1 (ja)
FI (1) FI68234C (ja)
GR (1) GR74076B (ja)
HU (1) HU182544B (ja)
IE (1) IE48827B1 (ja)
IL (1) IL58087A (ja)
IN (1) IN153099B (ja)
MX (1) MX6521E (ja)
NO (1) NO152445C (ja)
NZ (1) NZ191483A (ja)
PH (1) PH16315A (ja)
PL (2) PL119685B1 (ja)
PT (1) PT70180A (ja)
RO (1) RO77565A (ja)
YU (1) YU41884B (ja)
ZA (1) ZA793973B (ja)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2012236838A (ja) * 2003-10-03 2012-12-06 Three M Innovative Properties Co ピラゾロピリジンおよびその類似物

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4340726A (en) * 1980-03-14 1982-07-20 Newport Pharmaceuticals International, Inc. Esters
US4451478A (en) * 1982-03-12 1984-05-29 Newport Pharmaceuticals International, Inc. Imidazole compounds
US4849411A (en) * 1982-11-09 1989-07-18 Scripps Clinic And Research Foundation Modulation of animal cellular responses with compositions containing 8-substituted guanine derivatives
US5147636A (en) * 1982-11-09 1992-09-15 Scripps Clinic And Research Foundation Modulation of animal cellular responses with compositions containing 8-substituted guanine derivatives and interferons
HUT36464A (en) * 1983-05-24 1985-09-30 Newport Pharmaceuticals Process for producing erythro-4-amino-3-/2-hydroxy-3-alkyl/-imidazol-5-carboxamide
IT1215339B (it) * 1987-01-14 1990-02-08 Co Pharma Corp Srl Procedimento per la preparazione di 9-(idrossialchil)-ipoxantine
US5091432A (en) * 1990-03-28 1992-02-25 Glasky Alvin J 9-substituted hypoxanthine bi-functional compounds and their neuroimmunological methods of use
US5614504A (en) * 1990-08-01 1997-03-25 The University Of South Florida Method of making inosine monophosphate derivatives and immunopotentiating uses thereof
US6338963B1 (en) 1994-07-25 2002-01-15 Neotherapeutics, Inc. Use of carbon monoxide dependent guanylyl cyclase modifiers to stimulate neuritogenesis
NZ291592A (en) 1994-07-25 2001-03-30 Michel P Rathbone Use of carbon monoxide dependent guanylyl cyclase modulating purine derivative for treating neurological diseases
CA2199615A1 (en) * 1996-02-12 1997-08-14 Elie Abushanab Erythro-hydroxynonyladenine analogs with enhanced lipophilic and anti-ischemia traits
WO1999057120A1 (en) 1998-05-04 1999-11-11 Neotherapeutics, Inc. Novel serotonin-like 9-substituted hypoxanthine and methods of use
US6297226B1 (en) 1999-10-15 2001-10-02 Neotherapeutics, Inc. Synthesis and methods of use of 9-substituted guanine derivatives
US6288069B1 (en) 1999-11-16 2001-09-11 Neotherapeutics, Inc. Use of 9-substituted hypoxanthine derivatives to stimulate regeneration of nervous tissue
US6407237B1 (en) 2001-02-21 2002-06-18 Neotherapeutics, Inc. Crystal forms of 9-substituted hypoxanthine derivatives
US6849735B1 (en) 2000-06-23 2005-02-01 Merck Eprova Ag Methods of synthesis for 9-substituted hypoxanthine derivatives
AU2001271908A1 (en) 2000-07-07 2002-01-21 Neotherapeutics, Inc. Methods for treatment of disease-induced peripheral neuropathy and related conditions
US6759427B2 (en) * 2001-04-20 2004-07-06 Spectrum Pharmaceuticals, Inc. Synthesis and methods of use of tetrahydroindolone analogues and derivatives
US20030055249A1 (en) * 2001-07-17 2003-03-20 Fick David B. Synthesis and methods of use of pyrimidine analogues and derivatives
WO2005074946A1 (en) * 2004-02-10 2005-08-18 Adenobio N.V. Stable and active complexes of adenosine and adenosine phosphates with aminoalcohols for the treatment of pulmonary artery hypertension, cardiac failure and other diseases

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3215696A (en) * 1965-11-02 Substituted adenines -and preparation thereof
BE755361A (fr) * 1969-08-28 1971-03-01 Newport Pharmaceuticals Derives de l'inosine
US3728450A (en) * 1969-08-28 1973-04-17 Newport Pharmaceuticals Inosine derivatives
US3857940A (en) * 1971-05-21 1974-12-31 Newport Pharmaceuticals Inosine derivatives
US3836656A (en) * 1972-02-07 1974-09-17 Sandoz Ag Substituted purines as hypolipidemics
US3862189A (en) * 1973-08-14 1975-01-21 Warner Lambert Co Aralkyl-substituted purines and pyrimidines as antianginal bronchodilator agents
US4060616A (en) * 1976-03-01 1977-11-29 Burroughs Wellcome Co. Purine derivatives with repeating unit
YU96177A (en) * 1976-04-24 1982-08-31 Wuelfing Johann A Process for obtaining adenine derivatives

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2012236838A (ja) * 2003-10-03 2012-12-06 Three M Innovative Properties Co ピラゾロピリジンおよびその類似物

Also Published As

Publication number Publication date
EP0009154A1 (en) 1980-04-02
IE791753L (en) 1980-03-15
ES484167A1 (es) 1980-09-01
US4221909A (en) 1980-09-09
YU41884B (en) 1988-02-29
PL119685B1 (en) 1982-01-30
YU224579A (en) 1983-12-31
PT70180A (en) 1979-10-01
AU527851B2 (en) 1983-03-24
DD146049A5 (de) 1981-01-21
FI68234C (fi) 1985-08-12
FI68234B (fi) 1985-04-30
EP0009154B1 (en) 1982-12-08
HU182544B (en) 1984-02-28
JPH031309B2 (ja) 1991-01-10
IE48827B1 (en) 1985-05-29
KR840000552A (ko) 1984-02-25
RO77565A (ro) 1981-11-04
AU5055779A (en) 1980-03-20
PL218317A1 (ja) 1980-06-16
NZ191483A (en) 1983-06-14
PH16315A (en) 1983-09-05
ZA793973B (en) 1980-09-24
IL58087A (en) 1983-03-31
GR74076B (ja) 1984-06-06
FI792849A (fi) 1980-03-16
DK149857B (da) 1986-10-13
DK385679A (da) 1980-03-16
MX6521E (es) 1985-06-27
NO792792L (no) 1980-03-18
ATE1949T1 (de) 1982-12-15
IN153099B (ja) 1984-06-02
NO152445C (no) 1985-10-02
CA1122217A (en) 1982-04-20
NO152445B (no) 1985-06-24
DE2964211D1 (en) 1983-01-13
DK149857C (da) 1987-03-02
PL124515B1 (en) 1983-01-31
CS251060B2 (en) 1987-06-11

Similar Documents

Publication Publication Date Title
JPS5547683A (en) Immunity controlling agent and antivirulent
PT77410A (en) Process for the preparation of a fungicidal composition containing substituted 1-hydroxymethyltriazolyl derivatives
DE3372362D1 (en) Polyprenylcarboxylic acid amides and process for preparing the same
AU568578B2 (en) Corrosion inhibitors
IL69292A (en) Muramyl peptides substituted by 1,2-diacylated-sn-glycero-3-hydroxyphosphoryl,their manufacture and pharmaceutical compositions containing them
GR78685B (ja)
ES8505806A1 (es) Procedimiento para preparar nuevas sales de alquil(mixto) sulfonio de n-fosfonome-tilglicina
EP0257572A3 (en) Thyronin derivatives
ES8206434A1 (es) Procedimiento para la preparacion de composiciones de sales amonicas cuaternarias para el tratamiento de textiles
TW328083B (en) New derivatives of β-methoxy acrylic acid, their preparation process and their use as pesticides
EG18552A (en) Microbicidal agrochemical compositions
ES8106147A1 (es) Procedimiento para preparar un 1,2,4-triazol-3-tiol
GB2011399A (en) Bactericidal compositions
ES8304540A1 (es) Un procedimiento para producir una nueva carboxiamidoamina-sustituida.